Background and Objective: The persistence of new enhancing T1 hypointense lesions (acute black holes, ABHs) in multiple sclerosis (MS) cannot be predicted visually at lesion onset. Texture analysis using the polar Stockwell transform (PST) applied to conventional MR images however shows promise in quantifying tissue injury early. The objective of this study was to explore whether ABHs that persist (pABHs) differ from those that are transient (tABHs) using PST texture analysis.
Methods: Fifteen ABHs (8 pABHs; 7 tABHs) from 9 patients were analyzed on 3T images obtained during a clinical trial. Persistence was defined as remaining T1 hypointense 5–8 months later. NAWM regions were examined to control for changes unrelated to ABHs.
Results: At first appearance, there was higher coarse texture indicating greater tissue damage in the pABHs than in the tABHs (p < 0.01). Both had greater coarse texture than the contralateral and general NAWM (p ≤ 0.01). No difference was identified in normalized signal intensity between pABHs and tABHs and neither demonstrated location preference. While tABHs tended to be smaller than pABHs there was no correlation between lesion size and texture (r = 0.44, p > 0.05). Furthermore, coarse texture content appeared to predict persistence of individual lesions.
Conclusions: This preliminary study suggests that PST texture could predict persistence of tissue injury based on the severity of structural disorganization within acute lesions. While confirmation of this data is required texture analysis may prove to be a valuable tool to quantify tissue damage and predict recovery in proof-of-concept neuroprotection and repair trials.
Van WalderveenMALycklamaANGJAderHJ. Hypointense lesions on T1-weighted spin-echo magnetic resonance imaging: relation to clinical characteristics in subgroups of patients with multiple sclerosis. Arch Neurol2001; 58: 76–81.
2.
BitschAKuhlmannTStadelmannCLassmannHLucchinettiCBruckW. A longitudinal MRI study of histopathologically defined hypointense multiple sclerosis lesions. Ann Neurol2001; 49: 793–796.
3.
BagnatoFJeffriesNRichertND. Evolution of T1 black holes in patients with multiple sclerosis imaged monthly for 4 years. Brain2003; 126: 1782–1789.
4.
FilippiMRovarisMRoccaMASormaniMPWolinskyJSComiG. Glatiramer acetate reduces the proportion of new MS lesions evolving into ‘black holes’. Neurology2001; 57: 731–733.
5.
Van WaesbergheJHKamphorstWDe GrootCJ. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol1999; 46: 747–754.
6.
RivaMIkonomidouVNOstuniJJ. Tissue-specific imaging is a robust methodology to differentiate in vivo T1 black holes with advanced multiple sclerosis-induced damage. AJNR Am J Neuroradiol2009; 30: 1394–1401.
7.
PirkoIJohnsonAGamezJMacuraSIRodriguezM. Disappearing ‘T1 black holes’ in an animal model of multiple sclerosis. Front Biosci2004; 9: 1222–1227.
8.
BarkhofFvan WaesbergheJHFilippiM. T(1) hypointense lesions in secondary progressive multiple sclerosis: effect of interferon beta-1 b treatment. Brain2001; 124: 1396–1402.
9.
TruyenLvan WaesbergheJHvan WalderveenMA. Accumulation of hypointense lesions (‘black holes’) on T1 spin-echo MRI correlates with disease progression in multiple sclerosis. Neurology1996; 47: 1469–1476.
10.
BarkhofFHulstHEDrulovicJUitdehaagBMMatsudaKLandinR. Ibudilast in relapsing–remitting multiple sclerosis: a neuroprotectant?Neurology2010; 74: 1033–1040.
11.
BarkhofFCalabresiPAMillerDHReingoldSC. Imaging outcomes for neuroprotection and repair in multiple sclerosis trials. Nat Rev Neurol2009; 5: 256–266.
12.
van den ElskampIJLembckeJDattolaV. Persistent T1 hypointensity as an MRI marker for treatment efficacy in multiple sclerosis. Mult Scler2008; 14: 764–769.
13.
BarkhofFBruckWDe GrootCJ. Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance. Arch Neurol2003; 60: 1073–1081.
14.
WerringDJClarkCABarkerGJThompsonAJMillerDH. Diffusion tensor imaging of lesions and normal-appearing white matter in multiple sclerosis. Neurology1999; 52: 1626–1632.
15.
NaismithRTXuJTutlamNT. Increased diffusivity in acute multiple sclerosis lesions predicts risk of black hole. Neurology2010; 74: 1694–1701.
16.
YuOSteibelJMaussY. Remyelination assessment by MRI texture analysis in a cuprizone mouse model. Magn Reson Imaging2004; 22: 1139–1144.
17.
ZhangYWellsJBuistRPeelingJYongVWMitchellJR. A novel MRI texture analysis of demyelination and inflammation in relapsing–remitting experimental allergic encephalomyelitis. Med Image Comput Comput Assist Interv2006; 9: 760–767.
18.
ZhangJTongLWangLLiN. Texture analysis of multiple sclerosis: a comparative study. Magn Reson Imaging2008; 26: 1160–1166.
19.
YuOMaussYZollnerGNamerIJChambronJ. Distinct patterns of active and non-active plaques using texture analysis on brain NMR images in multiple sclerosis patients: preliminary results. Magn Reson Imaging1999; 17: 1261–1267.
20.
MathiasJMToftsPSLosseffNA. Texture analysis of spinal cord pathology in multiple sclerosis. Magn Reson Med1999; 42: 929–935.
21.
ZhuHGoodyearBGLauzonML. A new local multiscale Fourier analysis for MRI. Med Phys2003; 30: 1134–1141.
22.
StockwellRGMansinhaLLoweRP. Localization of the complex spectrum: The S transform. IEEE Trans Signal Process1996; 44: 998–1001.
23.
Zhu H, Zhang Y, Wei X, Metz LM and Mitchell JR. MR multi-spectral texture analysis using space-frequency information. METMBS Proceedings 2004.
24.
ZhangYZhuHMitchellJRCostelloFMetzLM. T2 MRI texture analysis is a sensitive measure of tissue injury and recovery resulting from acute inflammatory lesions in multiple sclerosis. Neuroimage2009; 47: 107–111.
25.
MetzLMLiDTraboulseeA. Glatiramer acetate in combination with minocycline in patients with relapsing–remitting multiple sclerosis: results of a Canadian, multicenter, double-blind, placebo-controlled trial. Mult Scler2009; 15: 1183–1194.
26.
SledJGZijdenbosAPEvansAC. A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging1998; 17: 87–97.
27.
JenkinsonMBannisterPBradyMSmithS. Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage2002; 17: 825–841.
28.
DrabyczSStockwellRGMitchellJR. Image texture characterization using the discrete orthonormal S-transform. J Digit Imaging2009; 22: 696–708.
29.
BruckWBitschAKolendaHBruckYStiefelMLassmannH. Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann Neurol1997; 42: 783–793.
ZhangYMooreGRLauleC. MRI texture correlates of pathological findings in post-mortem multiple sclerosis brain. #2074, proceedings of ISMRM. 2010.
32.
VrenkenHGeurtsJJKnolDL. Normal-appearing white matter changes vary with distance to lesions in multiple sclerosis. AJNR Am J Neuroradiol2006; 27: 2005–2011.
33.
BitschABruhnHVougioukasV. Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. AJNR Am J Neuroradiol1999; 20: 1619–1627.
34.
LassmannHBruckWLucchinettiCRodriguezM. Remyelination in multiple sclerosis. Mult Scler1997; 3: 133–136.
35.
FranklinRJFfrench-ConstantC. Remyelination in the CNS: from biology to therapy. Nat Rev Neurosci2008; 9: 839–855.
36.
TozerDJMarongiuGSwantonJKThompsonAJMillerDH. Texture analysis of magnetization transfer maps from patients with clinically isolated syndrome and multiple sclerosis. J Magn Reson Imaging2009; 30: 506–513.
37.
LerskiRASchadLRLuypaertR. Multicentre magnetic resonance texture analysis trial using reticulated foam test objects. Magn Reson Imaging1999; 17: 1025–1031.
